Jane Street Group, LLC Fulgent Genetics, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$19.6 - $25.06 $19.6 Million - $25.1 Million	1,000,100 New	1,000,100 $21.7 Million
Q1 2022 May 17, 2022	BUY	$49.85 - $96.11 $1.82 Million - $3.52 Million	36,600 Added 39.57%	129,100 $8.06 Million
Q4 2021 Feb 15, 2022	SELL	$77.3 - $105.0 $30,920 - $42,000	-400 Reduced 0.43%	92,500 $9.31 Million
Q3 2021 Nov 16, 2021	SELL	$74.87 - $110.87 $5.37 Million - $7.95 Million	-71,700 Reduced 43.56%	92,900 $8.36 Million
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $2.47 Million - $3.72 Million	-37,000 Reduced 18.35%	164,600 $15.2 Million
Q1 2021 May 18, 2021	BUY	$59.3 - $183.85 $6.31 Million - $19.6 Million	106,400 Added 111.76%	201,600 $19.5 Million
Q4 2020 Feb 17, 2021	BUY	$31.01 - $52.1 $2.6 Million - $4.36 Million	83,700 Added 727.83%	95,200 $4.96 Million
Q3 2020 Nov 17, 2020	BUY	$15.89 - $50.51 $182,735 - $580,865	11,500 New	11,500 $460,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.